Mckesson corporation (MCK)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Dec'08Sep'08Jun'08
Operating Activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

1,120

-702

-418

812

255

-86

349

-148

297

5,005

4,690

4,958

5,153

1,974

1,975

2,281

2,310

2,010

1,874

1,721

1,543

1,764

1,318

1,245

1,258

1,152

1,385

1,382

1,338

1,600

1,602

1,497

1,403

1,304

1,159

1,190

1,202

1,128

1,299

1,273

1,263

1,196

850

876

823

0

0

0

Adjustments to reconcile to net cash provided by operating activities:
Gain (Loss) on Disposition of Business

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Asset Impairment Charges

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred taxes

342

368

251

-160

-189

-149

850

908

868

87

-1,014

-936

-882

-156

49

-72

-64

-127

-80

-56

-171

-5

20

-57

-17

-202

-368

-443

-615

-689

-547

-414

-175

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

Share-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

154

151

149

143

137

130

127

123

114

110

99

95

99

0

0

0

Gain on business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81

81

81

81

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Credits associated with last-in, first-out inventory method

-252

-260

-215

-204

-210

-158

-139

-146

-99

139

-14

-28

-7

-122

66

200

244

265

327

330

337

412

459

409

311

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity earnings and charges from investment in Change Healthcare Joint Venture

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) from sales of businesses and investments

-

-

-

-

-

-

-

-

-

-

-

-

-94

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash items

-615

-689

-334

-252

-52

-47

53

19

-67

-78

-180

-181

-203

-19

-106

-117

-108

-237

-30

-54

-47

4

-136

-111

-130

-124

-87

-85

-90

-67

-88

-122

-93

-29

43

-8

-12

-104

-161

-70

20

-26

9

-17

-99

0

0

0

Changes in assets and liabilities, net of acquisitions:
Receivables

2,494

468

128

614

967

-678

-282

-124

-1,175

1,154

917

825

762

944

1,577

1,508

1,957

1,673

2,327

2,877

2,821

2,808

2,006

1,422

868

624

286

269

-318

126

122

125

768

1,050

963

1,040

673

-84

329

262

133

2,004

994

718

708

0

0

0

Impact of accounts receivable sales facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Inventories

376

301

-361

109

368

-196

-361

513

458

716

1,059

-382

-320

-772

-380

737

1,251

1,961

2,491

1,886

2,144

2,375

2,069

2,015

1,182

1,134

314

116

60

-5

594

583

882

855

564

-92

-367

555

144

768

782

325

-225

-56

-370

0

0

0

Drafts and accounts payable

3,952

872

-424

2,071

1,976

-757

-340

-160

271

1,382

1,706

984

2,070

3,498

3,514

3,848

3,302

2,339

5,215

4,354

4,718

5,905

3,531

3,190

2,412

1,534

843

1,397

-125

-677

533

659

2,037

2,117

1,830

898

533

261

112

1,064

1,340

558

605

-162

-189

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-112

-116

-107

-120

-188

-146

-133

-141

-88

-102

-99

-81

-128

-454

-76

-44

47

84

63

97

82

411

61

42

52

43

42

27

-86

-97

-86

-55

0

0

0

Taxes

-8

47

74

48

-95

-149

486

628

671

783

81

33

146

-140

-130

-188

-78

95

47

117

-222

-136

149

53

218

143

23

75

-98

-242

-228

-166

19

0

0

0

-

-

-

-

-

-

-

-

-47

0

0

0

Deferred tax expense (benefit) on litigation charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other

8

-246

-372

-165

-68

160

-3

79

-79

106

219

297

458

93

247

-9

-137

152

-194

-168

-42

41

25

-17

17

-192

-121

21

11

14

130

191

5

124

151

163

144

16

4

-56

-21

103

320

283

17

0

0

0

Payments for Legal Settlements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

483

470

458

293

26

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

4,374

3,615

3,559

5,046

4,036

3,165

3,324

2,543

4,345

2,756

3,155

3,626

4,744

6,415

5,349

5,077

3,672

2,449

4,198

3,384

3,112

3,893

2,488

2,602

3,136

2,679

2,837

3,751

2,483

1,510

2,014

2,072

2,950

2,716

2,935

2,136

2,338

1,929

1,581

1,937

2,316

2,342

2,336

1,944

1,351

0

0

0

Investing Activities
Payments for property, plant and equipment

362

359

374

412

426

445

419

431

405

427

417

403

404

462

461

487

488

367

364

370

376

368

335

292

278

287

291

265

241

196

178

208

221

246

252

239

233

219

213

209

199

181

208

197

195

0

0

0

Capitalized software expenditures

144

131

119

111

131

148

154

176

175

158

160

163

158

167

182

184

189

196

185

179

169

151

155

142

141

156

150

158

159

151

151

159

177

181

181

171

155

156

158

170

179

194

203

203

197

0

0

0

Payments to Acquire Businesses, Net of Cash Acquired

133

136

160

125

905

1,780

1,859

2,234

2,893

2,017

4,045

3,878

4,212

4,189

2,070

1,853

40

155

150

162

170

4,558

4,549

4,574

4,634

1,412

1,738

1,839

1,873

1,424

1,108

1,053

1,051

0

0

0

-

-

-

-

-

-

-

-

358

0

0

0

Proceeds from sale of businesses and investments, net and Payments received on Healthcare Technology Net Asset Exchange, net

-

-

-

-

-

-

-

-

-

-

-

-

206

0

0

0

-

204

221

99

15

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash for acquisitions

-

-

-

-

-

-

-

-

-

-

-

-

-

4

4

22

939

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-23

114

131

88

20

-136

-111

-71

20

43

51

-133

-73

41

25

173

111

-48

-39

-12

-23

47

181

109

136

89

-47

-19

-64

85

67

78

53

-43

-7

0

53

0

0

0

-

-

-

-

-15

0

0

0

Net cash used in investing activities

-579

-639

-683

-635

-1,381

-2,192

-2,111

-2,270

-2,993

-1,602

-3,788

-3,713

-3,269

-4,948

-2,834

-2,694

-1,557

-466

-439

-582

-677

-5,063

-5,079

-4,974

-5,046

-1,847

-2,132

-2,243

-2,209

-1,856

-1,504

-1,498

-1,502

-588

-878

-699

-624

-572

-212

-302

-309

-398

-466

-451

-727

0

0

0

Financing Activities
Proceeds from short-term borrowings

21,437

22,725

26,200

30,839

37,265

38,235

31,813

27,296

20,542

18,190

16,748

10,569

8,294

2,832

70

1,037

1,561

2,208

2,811

2,726

3,100

8,354

7,720

6,885

6,080

1,250

1,250

2,325

2,225

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

3,630

0

0

0

Repayments of short-term borrowings

21,437

21,665

27,048

32,873

37,268

37,938

30,724

25,267

20,725

18,852

16,450

10,573

8,124

1,425

204

1,168

1,688

2,500

3,081

2,939

3,152

8,302

7,554

6,779

6,132

1,250

1,250

2,325

2,625

1,525

1,525

400

0

0

0

0

-

-

-

-

-

-

-

-

-3,630

0

0

0

Proceeds from issuances of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

4,127

4,127

4,130

4,124

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of long-term debt

-

-

-

-

-

-

-

-

2,287

2,538

2,152

2,143

1,601

210

1,094

1,693

1,598

1,116

620

29

353

581

579

576

348

0

0

0

-

-

-

-

430

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Common stock transactions:
Issuances

113

118

115

75

75

64

87

127

132

145

128

111

120

115

126

121

123

134

158

156

152

142

124

161

177

204

205

173

166

157

165

159

167

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Share repurchases, including shares surrendered for tax withholding

1,954

2,202

2,203

2,033

1,639

2,146

1,896

1,716

1,709

1,202

2,954

2,553

2,311

2,712

1,065

1,565

1,612

1,304

950

453

450

108

107

105

130

929

1,289

1,288

1,214

1,615

1,255

1,255

1,874

1,174

1,175

1,706

2,050

1,549

1,548

1,041

323

0

0

0

-

0

0

0

Common stock issuances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

-

0

0

0

Dividends paid

294

298

301

296

292

286

280

271

262

253

245

249

253

257

259

251

244

235

226

227

227

231

230

220

214

201

193

194

194

196

198

201

195

191

188

185

171

159

145

130

131

131

132

133

116

0

0

0

Other

-301

-364

-378

-339

-355

-316

-282

-245

-185

-169

-138

-106

-18

90

61

-3

5

-150

-82

-43

-41

39

-13

29

62

52

62

50

31

43

48

49

27

36

16

68

54

82

84

44

40

4

18

3

4

0

0

0

Net cash used in financing activities

-2,734

-2,798

-3,628

-4,640

-2,227

-1,620

-1,614

-412

-3,084

-2,071

-3,227

-3,118

-2,069

-2,351

-2,377

-3,332

-3,453

-2,963

-1,990

-1,004

-968

3,440

3,488

3,525

3,619

-1,111

-560

-604

-956

-1,126

-1,653

-1,662

-1,905

-1,142

-1,150

-1,606

-1,841

-1,580

-1,530

-1,021

-421

290

240

5

178

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-19

38

-10

-23

-119

-123

-46

-3

150

158

17

-57

-144

-88

-33

-27

45

-201

-214

-268

-319

-114

-53

47

28

-16

-16

-12

-11

7

31

-15

-6

-8

-14

20

8

8

-4

7

36

19

-18

-41

-55

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

1,042

216

-762

-252

309

-770

-447

-142

-1,582

-759

-3,843

-3,262

-738

-972

105

-976

-1,293

-1,181

1,555

1,530

1,148

2,156

844

1,200

1,737

-295

129

892

-693

-1,465

-1,112

-1,103

-463

978

893

-149

-119

-215

-165

621

1,622

2,253

2,092

1,457

747

0

0

0

Supplemental Cash Flow Information